Cargando…
Characterization of rare transforming KRAS mutations in sporadic colorectal cancer
KRAS mutational status has been shown to be a predictive biomarker of resistance to anti-EGFR monoclonal antibody (mAb) therapy in patients with metastatic colorectal cancer. We report the spectrum of KRAS mutation in 1506 patients with colorectal cancer and the identification and characterization o...
Autores principales: | Tong, Joanna HM, Lung, Raymond WM, Sin, Frankie MC, Law, Peggy PY, Kang, Wei, Chan, Anthony WH, Ma, Brigette BY, Mak, Tony WC, Ng, Simon SM, To, Ka Fai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049792/ https://www.ncbi.nlm.nih.gov/pubmed/24642870 http://dx.doi.org/10.4161/cbt.28550 |
Ejemplares similares
-
Cardiac abnormalities in patients with septic shock detected by speckle tracking echocardiography
por: Ng, PY, et al.
Publicado: (2015) -
Yin Yang 1 contributes to gastric carcinogenesis and its nuclear expression correlates with shorter survival in patients with early stage gastric adenocarcinoma
por: Kang, Wei, et al.
Publicado: (2014) -
Novel KRAS Gene Mutations in Sporadic Colorectal Cancer
por: Naser, Walid M., et al.
Publicado: (2014) -
Percutaneous embolization of sporadic lumbar nerve root haemangioblastoma under local anaesthesia
por: Leung, Ho Sang, et al.
Publicado: (2020) -
The Impact of KRAS Mutation in Patients With Sporadic Nonampullary Duodenal Epithelial Tumors
por: Kinugasa, Hideaki, et al.
Publicado: (2021)